Pure Global: ASEAN's New MedTech Gateway in Malaysia & Thailand

This week, we dive into the new medical device regulatory reliance pilot program launched between Malaysia and Thailand. This collaboration creates a powerful fast-track for market access in the ASEAN region, allowing companies to leverage an approval in one country to accelerate registration in the other, but the pathway is filled with critical nuances. We explore how this program fundamentally changes the strategic map for Southeast Asia. It's a game-changer for companies that previously faced the costly and time-consuming process of separate submissions, but success requires more than just a prior approval. **Case In Point:** A US-based startup with a novel Class B device secured approval in Thailand. They thought the new reliance program meant a simple, automatic entry into Malaysia. They were wrong. Their submission was rejected due to a failure to meet Malaysia's specific labeling and local representation requirements, a costly mistake that could have been avoided and delayed their market entry by months. **In this episode, you will learn:** - What specific device classes are eligible for the Malaysia-Thailand reliance pilot? - How does this reliance pathway differ from other international programs like MDSAP? - What are the top three documentation mistakes that can get your application rejected? - Do you still need a separate local authorized representative in both countries? - How does this pilot affect post-market surveillance and vigilance reporting? - What is the expected timeline and cost savings compared to traditional submissions? - Could this program be a model for a future, unified ASEAN regulatory framework? For more information, contact us at [email protected], visit https://pureglobal.com/, or access our FREE AI tools and medical device database at https://pureglobal.ai/.